| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Previous Article | Next Article ![]()
Eukaryotic Cell, February 2005, p. 476-483, Vol. 4, No. 2
1535-9778/05/$08.00+0 doi:10.1128/EC.4.2.476-483.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Laboratoire de Génétique Moléculaire des Champignons, Institut de Biochimie et de Génétique Cellulaires, UMR 5095 CNRS-Université de Bordeaux 2, Bordeaux, France
Received 18 October 2004/ Accepted 1 December 2004
| ABSTRACT |
|---|
|
|
|---|
-helical fold. We have then used a systematic evolution of ligands by exponential enrichment procedure to identify the sequence bound by the IDI-4 bZIP domain. The IDI-4 binding site consensus sequence corresponds to the ATGANTCAT pseudopalindrome. IDI-4 binding sites are present in the promoter region of the idi-7 gene, and the bZIP IDI-4 peptide binds to the idi-7 promoter in vitro. The identified IDI-4 consensus binding sequence is very similar to the GCN4/CPC binding site, raising the possibility of an interplay and/or partial functional redundancy between IDI-4 and CPC-type bZIP factors in fungi. | INTRODUCTION |
|---|
|
|
|---|
In filamentous fungi, when cells of unlike genotype fuse, a cell death reaction occurs and the fusion cells are rapidly destroyed. This cell death reaction is termed heterokaryon incompatibility and is triggered by genetic differences at specific loci (het loci) (7). A given species displays about 10 different het loci, and a genetic difference at any given het locus is sufficient to trigger incompatibility. Although molecular identification of het genes in several fungal species has been achieved, the modalities of cell death execution remain largely elusive. In Podospora anserina, this cell death reaction involves the induction of autophagy and the transcriptional activation of a set of genes termed idi (induced during incompatibility) genes (2, 19). Among them are the idi-6 and idi-7 genes, which encode proteins involved in autophagy. idi-6 is the ortholog of the Saccharomyces cerevisiae gene prB1 and encodes a vacuolar protease, while idi-7 is the ortholog of ATG8 and encodes a protein involved in autophagosome formation (19). All idi genes are also induced by rapamycin, a specific inhibitor of the TOR kinase pathway (4). This finding led to the suggestion that incompatibility triggers an autophagic cell death program controlled by the TOR pathway (4, 19). However, the mechanism of induction of this autophagic cell death program remains largely unknown.
We have recently characterized idi-4, a novel idi gene encoding a basic leucine zipper (bZIP) transcription factor (5). The 25-kDa IDI-4 protein displays a putative N-terminal trans-activation domain and a C-terminal bZIP domain. The IDI-4 bZIP domain displays similarity to the jblA Aspergillus nidulans bZIP factor (20) and also to the fungal cross-pathway control (CPC) bZIP factors of the GCN4 type which control amino acid metabolism in response to nutrient starvation (5). Putative idi-4 orthologs exist in a number of filamentous ascomycetes including Neurospora crassa, Magnaporthe grisea, and Fusarium graminearum. jblA and idi-4 are both induced by amino acid starvation; they are not GCN4/CPC orthologs but are likely to represent an independent gene family of fungal bZIP factors (5, 20). idi-4 is induced at the transcriptional level during cell death by incompatibility but also by rapamycin and various stress conditions. The constitutive or inducible overexpression of idi-4 leads to cell death. The idi-4-induced cell death mimics several aspects of cell death by incompatibility. In particular, we found that the overexpression of idi-4 induces autophagy. Then, at least two idi genes, namely idi-2 and idi-7, are induced upon increased expression of idi-4, suggesting that these genes are targets (either direct or indirect) of idi-4 (5). The fact that the overexpression of idi-4 induces cell death indicates that the genes responsible for execution of the cell death program are among the targets of this bZIP factor. In order to further characterize this cell death program and to understand how it is regulated, we set out to characterize the IDI-4 target DNA sequence. We have defined the in vitro DNA-binding specificity of IDI-4 by using a random selection approach (systematic evolution of ligands by exponential enrichment [SELEX]). We find that the IDI-4 bZIP domain binds a pseudopalindromic ATGANTCAT sequence closely resembling the GCN4/CPC binding site and binds to the idi-7 promoter sequence in vitro.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Glutaraldehyde cross-linking. For glutaraldehyde cross-linking, the bZIP IDI-4 protein at 10 µM in 50 mM sodium phosphate (pH 8) was incubated for various times with either 0.01 or 0.2% glutaraldehyde at 20°C. The reaction was stopped by the addition of 100 mM Tris-HCl (pH 8) and analyzed by SDS-PAGE followed by Coomassie blue staining.
Circular dichroism.
Circular dichroism (CD) spectra at 20°C in a solution containing 150 mM NaCl and 50 mM Tris-HCl (pH 8) were determined by using a Jasco 810 spectropolarimeter with quartz cells of 0.1 or 1 cm path length. Protein concentrations ranged from 0.15 to 15 µM. Deconvolution of the spectra was performed with the K2d program, available at http://www.embl-heidelberg.de/
andrade/k2d.html.
SELEX procedure. For the SELEX procedure, a library of 68-bp double-stranded random sequence oligonucleotides was generated by PCR with 5 ng of the N30 oligonucleotide [5'CGGGATCCTAAGTAGGTAG(N)30GACGTTAGCTATCTAGAGC 3'] as the template and 2 µg of oligonucleotide ADBam (5' CGGGATCCTAAGTAGGTAG 3') and 2 µg of oligonucleotide ADXba (5'GCTCTAGATAGCTAACGTC 3') as primers in a reaction volume of 100 µl. PCR conditions were 30 s at 95°C, 30 s at 58°C, and 1 s at 72°C for 25 cycles. The PCR products were analyzed on a 4% NuSieve FMC agarose gel. One microgram (20 pmol) of the 68-bp double-stranded random sequence oligonucleotide library was then incubated at 25°C in a volume of 100 µl with 10 pmol of purified IDI-4 bZIP protein in a solution containing 50 mM Tris-HCl (pH 8) and 100 mM NaCl with 1 mg of bovine serum albumin (BSA) ml1 and 10 µg of poly(dI-dC) ml1. After 30 min, 2 µl of TALON metal affinity resin suspension (BD Bioscience Clontech) equilibrated in a solution containing 50 mM Tris-HCl (pH 8) and 100 mM NaCl was added to the reaction mixture. Incubation was prolonged for 10 min, and then the reaction mixture was centrifuged for 1 min at 2,000 x g, the supernatant was discarded, and the pellet was washed four times in a 500-µl solution containing 50 mM Tris-HCl and 100 mM NaCl. The protein was then eluted from the resin with a 50-µl solution of 100 mM imidazole, 50 mM Tris-HCl, 100 mM NaCl, 100 µg of BSA ml1, and 1 µg of poly(dI-dC) ml1. The reaction was centrifuged for 1 min at 2,000 x g, and the supernatant was collected. Five microliters of the eluted fraction was amplified by PCR for 30 cycles in the same conditions as described above. The PCR product was ethanol precipitated, and 300 ng of the PCR product was submitted to a second SELEX cycle with the same conditions as above. Two more SELEX cycles were performed with the same conditions except that only 1 µl of a 100-fold dilution of the eluted fractions was used as the template in a 25-cycle PCR. After the fourth cycle, the PCR products were cloned in the pGEM-T vector (Promega), and inserts of 71 independent clones were sequenced.
Gel retardation assays.
For gel retardation experiments, probes were obtained with pGEM-T-cloned SELEX sequence as the template and oligonucleotides ADBam and ADXba as primers. The 68-bp fragment was gel purified on 4% NuSieve FMC agarose gels, digested with BamHI and XbaI, and labeled with [
-32P]dCTP (10,000 mCi/ml; Amersham) by using Klenow enzyme. Specific activity was about 100,000 cpm per ng of DNA. Binding reactions were performed for 15 min on ice in a volume of 10 µl with 0.2 ng of probe (20,000 cpm), 10 to 20 ng of purified bZIP IDI-4 protein in 50 mM Tris-HCl (pH 8), 150 mM NaCl, 20 ng of poly(dI-dC) µl1, and 0.3 µg of BSA µl1. Electrophoresis was performed in a Miniprotean II apparus (Bio-Rad) on a 5% acrylamide gel in 1x Tris-borate-EDTA at 4°C for 1 h at 100 V. After electrophoresis, the gels were dried for 45 min at 80°C under a vacuum. The probe corresponding to the idi-7 promoter or to the mutated idi-7 promoter was obtained by PCR with oligonucleotides IDI7.5 (5' GCCCTGATGATTCATACCGGGAC 3') and IDI7.3 (5' TCAAAGGTGAATCATATGGGGCG 3') or IDI7.5 M (5' GCCCTGATGCTGCATACCGGGAC 3') and IDI7.3 M (5' TCAAAGGTGCAGCATATGGGGCG 3') and the p1004GFP-idi-7 plasmid as the template (19). The positions of the introduced mutations are underlined. The concentration of unlabeled dNTPs was 50 µM. Five microliters of [
-32P]dCTP was added in a final reaction mixture volume of 20 µl. The specific activity of the probe was about 30,000 cpm per ng of DNA. Binding and electrophoresis were performed as described above except that 6.5% acrylamide gels were used and the process ran for 90 min at 150 V. Competitor fragments corresponded to unlabeled PCR products. The 249-bp P. anserina genomic DNA fragment used as a nonspecific competitor was obtained with oligonucleotides 173 (5' CGCCATCGACTTCGCCTATG 3') and 246 (5' TGCTGGCTGAGGGTGTTGTTG 3'). In the competition experiments, the bZIP IDI-4 protein was used at 250 nM.
Sequence analyses. Secondary structure prediction of the bZIP IDI-4 peptide were performed by using the GORIV method, available at http://pbil.ibcp.fr. Tertiary structure prediction was performed by using the Geno3D program, available at http://pbil.ibcp.fr. For identification of a consensus binding site, the sequences were analyzed with the Multiple EM for Motif Elucidation (MEME) program, http://meme.sdsc.edu/meme/website/meme.html (1). The sequences of the idi gene promoters or of random genomic P. anserina sequences were analyzed for occurrence of the putative IDI-4 binding site by using the FUZZNUC program at http://bioweb.pasteur.fr/seqanal/interfaces/fuzznuc.html. Genomic P. anserina sequences were recovered at http://podospora.igmors.u-psud.fr/.
| RESULTS |
|---|
|
|
|---|
|
|
-helical fold in vitro.
bZIP proteins bind DNA as dimers, and each monomer forms a single uninterrupted 55- to 65-amino-acid-long
-helix (6). The C-terminal leucine zipper region allows dimerization of the helices as parallel coils. The basic domains form a pair of tweezers which contact DNA on each side of the double helix. Typical bZIP domains, such as those of fos, jun, and GCN4, are unstructured in their monomeric form and adopt an
-helical fold only upon dimerization. bZIP domains thus unfold upon dimer dissociation induced by dilution (26, 27). In order to determine whether the bZIP IDI-4 peptide forms a dimer in vitro, we submitted the purified protein to glutaraldehyde cross-linking. The bZIP IDI-4 peptide was incubated for various times with either 0.01 or 0.2% glutaraldehyde and analyzed by SDS-PAGE. We found that over time, the amount of monomer decreases while a band appears at about 26 kDa, presumably corresponding to the covalently linked dimer. The experiment strongly suggests that bZIP IDI-4 peptide dimerizes in vitro.
Secondary structure prediction programs and homology-based three-dimensional modeling suggest that the IDI-4 bZIP domain adopts an
-helical fold (Fig. 1). We have analyzed the secondary structure content of the purified bZIP IDI-4 protein at 15 µM by using CD. The CD spectrum of the bZIP IDI-4 peptide displays two minima, at 208 and 222 nm, which are characteristic of
-helical secondary structures (Fig. 2). Deconvolution of this spectrum suggests that about 60% of the bZIP IDI-4 residues display an
-helical conformation. The CD spectrum was also recorded after a 10- or 100-fold dilution. In contrast to that which has been reported for the GCN4 bZIP domain, the mean residue ellipticity was not significantly affected by dilution (26, 27). This result indicates that in contrast to the GCN4 bZIP domain, the IDI-4 bZIP domain does not unfold at low protein concentrations (<1 µM). This observation suggests that the Kd for dimer formation is lower for the IDI-4 bZIP domain that for the GCN4 bZIP domain.
Together, these experiments suggest that the purified IDI-4 bZIP domain adopts its native
-helical fold and forms a stable dimer in vitro. The purified bZIP IDI-4 peptide thus appears well suited for functional studies.
Identification of the in vitro consensus binding site of IDI-4 by SELEX. We chose to identify the in vitro consensus binding sequence of the bZIP IDI-4 peptide by the SELEX procedure. This reiterative technique allows the identification of the sequence bound by a particular protein (or nucleic acid) from a pool of random-sequence DNA or RNA oligonucleotides. We generated a library of 68-bp-long double-stranded oligonucleotides displaying a random sequence segment of 30 bp flanked by 19 bp of adaptor sequences. This library was incubated with purified bZIP IDI-4 protein, and the sequences bound by the protein were amplified by PCR (see Materials and Methods). After four SELEX cycles, the amplified 68-bp sequences were used as probes in a gel shift experiment with the purified bZIP IDI-4 protein, and a specific shift was detected (data not shown). We concluded that sequences specifically bound by IDI-4 had been selected and decided to clone the amplified sequence. The sequences of 71 independent SELEX clones were determined and compared by using the MEME program (1) in order to identify common motifs. The MEME program retained 49 clones to define a 9-bp consensus motif. This motif is ATGANTCAT, a pseudopalindromic sequence with two TGA half-sites. The motif is highly statistically significant (E value, 1.3e-23). In other words, the probability of random occurrence of these motifs in our data set is very low. A simplified position-specific scoring matrix for this motif is given in Fig. 3 together with the sequences of 49 retained clones. In this motif, the two TGA half-sites appear critical. To a lesser extent, the A/T at positions 4 and +4 are also significant. In contrast to this data set, there appears to be no significant constraint on the central base in position 0. In order to verify that the identified motif is indeed bound by the bZIP IDI-4 peptide, we used one SELEX clone (clone 23, shown in boldface type in the list in Fig. 3) as a probe in gel shift experiments. We found that the bZIP IDI-4 peptide is able to bind specifically to this SELEX clone (Fig. 4).
|
|
The promoter of idi-7 contains potential bZIP IDI-4 binding sites. In a previous study, we found that increased expression of IDI-4 induces transcription of idi-2 and idi-7 (5). We analyzed the sequences of the idi-2 and idi-7 promoters for the presence of potential IDI-4 binding sites. One thousand five hundred base pairs of sequence upstream of the idi-2 and idi-7 transcription initiation sites were analyzed for the presence of sequences resembling the IDI-4 consensus binding site. The idi-7 promoter displays a perfect potential IDI-4 binding site at position 383 (ATGATTCAT) and an additional potential IDI-4 site with a single mismatch at +4 starting at position 203 (ATGATTCAC) (Fig. 5). In the idi-2 promoter sequence, no perfect IDI-4 sites were found, but a potential IDI-4 site with a single mismatch was found (ATCATTCAT; position 129). In both promoters, additional potential sites with two mismatches are found. To estimate the occurrence of ATGANTCAT sequences in the P. anserina genome, we scanned 1 Mb of genomic P. anserina sequence for the presence of ATGANTCAT sites. The exact consensus sequence had a mean distribution of 1 in 92,060 bp and had 1 in 3,821 or 1 in 295 bp when allowing one or two mismatches, respectively. The promoter sequences of all of the other known idi genes were analyzed. No perfect or single-mismatch IDI-4 binding sequences were found.
|
bZIP IDI-4 binds to the idi-7 promoter in vitro. In order to determine whether IDI-4 could indeed bind to the potential sites found in the idi-7 promoter, we used a 205-bp fragment from the idi-7 promoter (positions 389 to 185) as a probe in gel retardation experiments. We found that the bZIP IDI-4 leads to a mobility shift when incubated with this fragment. At high IDI-4 bZIP peptide concentrations (0.25 µM and higher), two bands are detectable (Fig. 5B). These two distinct complexes might reflect the existence of two IDI-4 binding sites, presumably the detected perfect and single-mismatch IDI-4 motifs (Fig. 5A). At high protein concentrations, nonspecific binding also occurred, leading to retention of the probe in the well of the gel.
In order to verify that the observed shifts are specific, we carried out a number of specificity controls. First, we performed competition experiments by using the unlabeled idi-7 fragment and nonspecific competitors (Fig. 5C). The unlabeled 205-bp idi-7 promoter fragment efficiently competed away the labeled probe. An unrelated 249-bp fragment (lacking perfect, single-mismatch, and double-mismatch IDI-4 motifs) or the nonspecific competitor poly(dI-dC) used at the same concentration did not significantly affect the amount of shifted probe (but reduced nonspecific binding). We also created a mutated version of the idi-7 promoter that was affected in both TGA half-sites of the two perfect and single-mismatch IDI-4 binding sites at positions 383 and 203 (ATGCTGCAT and ATGCTGCAC, respectively). This mutated 205-bp idi-7 promoter fragment was less efficient as a competitor than the wild-type idi-7 fragment, but slightly more efficient than poly(dI-dC) or the unrelated 249-bp fragment.
As a second specificity control, we compared the wild-type and mutated idi-7 promoter fragment probes in gel retardation experiments (Fig. 5D). The mutation in the two half-sites of the perfect and single-mismatch IDI-4 motifs strongly decreased IDI-4 binding. However, with the mutated probe, a faint shifted band was observed at a 250 nM concentration of protein. It thus appears, as suggested by the competition experiments reported above, that the mutated fragment can still be bound by IDI-4, but with a much lower affinity. It is possible to speculate that the overlapping double-mismatch IDI-4 motifs (position 286 to 271) might be responsible for this low-affinity binding when the perfect and single-mismatch sites are mutated.
We conclude from these experiments that the bZIP IDI-4 protein specifically binds to the idi-7 promoter in vitro. The presence of two distinct shifts suggests that bZIP IDI-4 binds the perfect and single-mismatch IDI-4 motifs found at positions 383 and 203.
| DISCUSSION |
|---|
|
|
|---|
The identified IDI-4 consensus binding sequence corresponds to the ATGANTCAT pseudopalindrome. This sequence is very similar to the binding sequence of the yeast bZIP GCN4 factor (8, 18) and of its orthologs in filamentous ascomycetes. The yeast GCN4 factor is a master regulator of gene expression and controls the cellular response to amino acid starvation (9). GCN4 binds the ATGACTCAT sequence in vitro (18), and the structure of the GCN4 dimer bound to its cognate site has been determined (6, 11, 12). Eleven of the 13 residues known to be involved in DNA contacts in GCN4 are strictly conserved or similar in IDI-4. This fact readily explains why the GCN4 and IDI-4 DNA-binding site are so similar. The difference between the IDI-4 and GCN4 binding sites resides in the fact that we found no significant constraint on the central base of the pseudopalindrome in the case of IDI-4. The only two positions for which IDI-4 and GCN4 differ by nonconservative changes in the basic DNA-binding domain are positions 11 and 17 (position 0 is the first leucine of the dimerization domain) (Fig. 1). Position 17 is a threonine in GCN4 (and GCN4 orthologs in filamentous fungi). This residue makes contacts with the phosphate backbone near the centre of the binding site (6, 11, 12). An asparagine residue is found at position 17 in the IDI-4 basic domain (Fig. 1). Interestingly, it has been shown that in GCN4, mutation of the 17 threonine residue to an asparagine increases the GCN4 binding register and decreases the constraint on the central base of the pseudopalindrome (21). This difference at position 17 could therefore be the structural basis of the difference in DNA-binding specificity between IDI-4 and GCN4. The conservation in the basic DNA-binding domain between IDI-4 and its putative orthologs in other filamentous ascomycetes is strong. It can thus be proposed that other fungal bZIP factors of the IDI-4-type might display the same specificity as IDI-4.
Our in vitro analyses suggest that the IDI-4 dimer is very stable; it withstands dissociation at concentrations below the micromolar range. The IDI-4 dimer also resists thermal denaturation at up to 85°C (S. J. Saupe, unpublished data). This high stability compared to GCN4 might be due to the fact that the leucine zipper of IDI-4 is composed of five heptad repeats instead of four. In addition to the hydrophobic residues at positions a and d of the heptad repeats, the vast majority (20 of 25) of the other residues of that region are charged. Salt bridges between these residues are likely to contribute greatly to the overall stability of the IDI-4 dimer. This stability might have important functional implications, as active dimers could form even at low cellular IDI-4 protein concentrations.
We have previously pointed out similarities between the IDI-4 and the GCN4/CPC-type bZIP factors (5, 20). Both IDI-4 and GCN4 can be induced by amino acid starvation and rapamycin, and both factors participate in the control of the induction of autophagy (4, 5, 14, 17, 22, 23). The present work shows that these two factors also bind remarkably similar sequences. Thus IDI-4 and GCN4/CPC-type factors might have not only common upstream regulators, but also common downstream targets. The bZIP IDI-4 domain can bind cross-pathway control recognition elements (CPREs) in vitro. Several fungal CPC factors display CPREs in their promoters. These CPREs allow positive autoregulation but might also represent potential targets for IDI-4 type factors (10, 13, 25). Our previous analyses have shown that inactivation of IDI-4 does not prevent induction of cell death by incompatibility and induction of idi genes (5). This observation indicates that transcriptional induction of cell death genes during incompatibility is redundantly mediated. The P. anserina CPC ortholog represents a prime candidate as an auxiliary factor mediating induction of idi genes and autophagy during incompatibility. In vivo studies are now required to address the possibility of a partial functional redundancy and/or interplay between IDI-4 and the P. anserina CPC ortholog.
| FOOTNOTES |
|---|
Present address: Plant and Microbial Biology Department, University of California, Berkeley, CA 94720-3102. ![]()
| REFERENCES |
|---|
|
|
|---|
kinase GCN2. J. Biol. Chem. 278:20457-20460.
kinase signaling pathway. Proc. Natl. Acad. Sci. USA 99:190-195.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Appl. Environ. Microbiol. | Infect. Immun. | J. Bacteriol. |
|---|---|---|
| Mol. Cell Biol. | Microbiol. Mol. Biol. Rev. | ALL ASM JOURNALS |